Skip to Main Content

October 10, 2025   
Health Law Weekly

FDA Unveils Program to Prioritize Review of Generic Drugs with Domestic Production

  • October 10, 2025

The Food and Drug Administration (FDA) is launching a new pilot prioritization program that will expedite the review of abbreviated new drug applications (ANDA) of generic companies that test and manufacture their products in the United States.

ARTICLE TAGS

You must be logged in to access this content.